New Blood Test Helps Detect Lynch Syndrome Earlier

Lynch syndrome is an inherited condition that significantly increases the risk of developing cancers, such as colorectal and endometrial cancer, often at a young age.

Currently, about 95% of people with Lynch syndrome are unaware they carry it, as it remains "silent" until cancer appears.

A major breakthrough from the University of Texas MD Anderson Cancer Center, published in Nature Communications, offers a potential solution.

Researchers have identified a new blood-based biomarker that detects unique "immune signatures" caused by Lynch syndrome.

By analyzing T cell receptors, this test identifies how the body responds to specific DNA mutations.

While the current "gold standard" for diagnosis remains germline genetic testing, this new non-invasive method represents a shift toward proactive health.